Product Details
Formula
C4H12NNaO7P2
MW
271.08
Purity
>97%
Solubility (DMSO Mg/MI)
INSOLUBLE
Storage (Powder)
3 Years -20?C
Storage (Solvent)
1 Year -80?C
Indication
N/A
Mode Of Action
inhibitor
Drug Status
Approved
Target Name
Farnesyl pyrophosphate (FPP) synthase
Research Area
ENDOCRINOLOGY
Research Area Sub Group
Bone Density Conservation
Pharmacology
ENZYMES
Pharmacology Area Sub Group
Synthase
Bio Chemical Notes
Alendronic acid is used in treatment of Paget's disease and osteoporosis in women. Action is through its affinity for hydroxyapatite and targetting of farnesyl pyrophosphate (FPP) synthase. Ref: Bioorganic & Medicinal Chemistry. 1996; 4 (1), 3